Get the latest news, insights, and market updates on HCA (HCA Healthcare, Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
What HCA Healthcare (HCA)'s Upward 2025 Revenue Outlook Means For Shareholders
Earlier in 2025, HCA Healthcare reported a US$3.8 billion rise in revenue for the first three quarters, prompting the company to increase its full-year revenue projections by as much as US$1 billion following substantial gains in admissions and volumes. While facing legal and regulatory hurdles, HCA's simultaneous expansion efforts and margin improvements set it apart among hospital operators, highlighting management's confidence in maintaining momentum despite sector headwinds. We will... Nov 17, 2025 - $HCA
RBC Capital Lifts HCA Healthcare, Inc. (HCA) Price Target Following Robust Revenue and Earnings Growth
HCA Healthcare Inc. (NYSE:HCA) is one of the best blue-chip stocks to buy now. On October 27, analysts at RBC Capital reiterated an Outperform rating on HCA Healthcare Inc. (NYSE:HCA) and raised the price target to $482 from $449. The price target was raised following the company’s strong third‑quarter results, reported on October 24, which […] Nov 15, 2025 - $HCA
1 Cash-Producing Stock on Our Buy List and 2 We Turn Down
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning. Nov 14, 2025 - $HCA
HCA Healthcare Surpasses 100,000 Pounds of Collected Medication in Year Seven of Annual "Crush the Crisis"
NASHVILLE, Tenn., November 13, 2025--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it collected 19,846 pounds, approximately 13.6 million doses, of unused or expired medications during its seventh annual "Crush the Crisis" national prescription drug take back day. In total, the organization has now collected more than 108,500 pounds of medication since launching "Crush the Crisis" as an enterprise initiative in 2019. Nov 13, 2025 - $HCA
What Catalysts Could Shift the Narrative for HCA Healthcare Stock?
HCA Healthcare stock has seen a modest bump in analyst price targets, with the consensus estimate rising from $471 to approximately $476.67 per share. This upward adjustment follows strong quarterly performance and improving payment trends noted by the analyst community. Stay tuned to discover how investors can monitor shifts in sentiment and keep ahead of changes in the stock’s outlook going forward. Analyst Price Targets don't always capture the full story. Head over to our Company Report... Nov 13, 2025 - $HCA
HCA Healthcare (HCA): Assessing Valuation After Revenue Growth, Florida Expansions, and Upbeat 2025 Outlook
HCA Healthcare (HCA) is drawing fresh attention as its recent results highlight a substantial rise in revenue, supported by growing patient demand and ongoing expansions across several Florida hospitals. See our latest analysis for HCA Healthcare. After a remarkable year packed with expanded services in Florida, new leadership appointments, and recognition for clinical quality, HCA Healthcare’s momentum has clearly caught investors’ attention. The company’s share price has soared, delivering... Nov 13, 2025 - $HCA
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" lets us enhance your experience and provide personalized content and ads.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple